Literature DB >> 16571200

Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections.

Marisa Baré1, Xavier Castells, Angel Garcia, Marta Riu, Mercè Comas, Maria José Gil Egea.   

Abstract

OBJECTIVES: The objective of this study is to describe the frequency of inappropriate empirical antibiotic therapy in secondary intra-abdominal infection and to identify the possible relationship between inappropriateness and some clinical outcomes.
METHODS: A retrospective descriptive multicenter study was conducted using hospital secondary databases developed at two university hospitals located in northeast Spain. Participants were patients 18 years of age or older who were diagnosed with community-acquired intra-abdominal infections between January 1, 1998, and December 31, 2000, identified through computerized patient records using ICD-9 codes. Appropriateness of empirical treatment was defined according to the recommendations of the literature. The clinical outcome of each patient was classified as one of the following: (i) resolved with initial therapy, (ii) required second-line antibiotics, (iii) required re-operation, or (iv) in-hospital death. The Fisher's exact test or the Chi-squared test for categorical variables and the t-test or Mann-Whitney test for continuous variables were used for comparing groups. Conditional logistic and linear regression analyses were also applied.
RESULTS: Of 376 cases, 51 cases (13.6 percent, 95 percent confidence interval, 10-17 percent) received inappropriate empirical antibiotic therapy according to the scientific literature. Inappropriate initial empirical treatment was significantly associated with the need for a second line of antibiotics (p < .001), although not with re-operation, mortality, or length of hospitalization.
CONCLUSIONS: Approximately 14 percent of the patients received inappropriate empirical antibiotic treatment. Worse clinical outcomes consistently were observed in the group of patients receiving inappropriate empirical treatment. The appropriateness of antibiotic treatment for a given infection, in light of the availability of clearly defined clinical guidelines is an easily evaluated aspect of the quality of care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571200     DOI: 10.1017/S0266462306051063

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  9 in total

1.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Characteristics of surgical patients receiving inappropriate empiric antimicrobial therapy.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Tjasa Hranjec; Rosemarie Metzger; Brian R Swenson; Robert G Sawyer
Journal:  J Trauma Acute Care Surg       Date:  2014-10       Impact factor: 3.313

3.  Antibiotic use among older adults on an acute care general surgery service.

Authors:  André S Pollmann; Jon G Bailey; Philip J B Davis; Paul M Johnson
Journal:  Can J Surg       Date:  2017-12       Impact factor: 2.089

4.  Peritonitis - the Western experience.

Authors:  Mark A Malangoni; Tazo Inui
Journal:  World J Emerg Surg       Date:  2006-09-05       Impact factor: 5.469

5.  Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).

Authors:  Joseph Solomkin; Ellie Hershberger; Benjamin Miller; Myra Popejoy; Ian Friedland; Judith Steenbergen; Minjung Yoon; Sylva Collins; Guojun Yuan; Philip S Barie; Christian Eckmann
Journal:  Clin Infect Dis       Date:  2015-02-10       Impact factor: 9.079

Review 6.  Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis.

Authors:  Gowri Raman; Esther Avendano; Samantha Berger; Vandana Menon
Journal:  BMC Infect Dis       Date:  2015-09-30       Impact factor: 3.090

7.  Carbapenem Treatment and Outcomes Among Patients With Culture-Positive Complicated Intra-abdominal Infections in US Hospitals: A Retrospective Cohort Study.

Authors:  Marya D Zilberberg; Brian H Nathanson; Kristen Ditch; Kenneth Lawrence; Melanie Olesky; Andrew F Shorr
Journal:  Open Forum Infect Dis       Date:  2019-11-25       Impact factor: 3.835

Review 8.  Anesthetic management for patients with perforation peritonitis.

Authors:  Kiran Sharma; Mritunjay Kumar; Upma Bhatia Batra
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10

Review 9.  Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections.

Authors:  Kellie J Goodlet; David P Nicolau; Michael D Nailor
Journal:  Ther Clin Risk Manag       Date:  2016-12-01       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.